Header Logo

Connection

Anthony Rothschild to Age Factors

This is a "connection" page, showing publications Anthony Rothschild has written about Age Factors.
Connection Strength

0.264
  1. Bingham KS, Whyte EM, Mulsant BH, Rothschild AJ, Rudorfer MV, Marino P, Banerjee S, Butters MA, Alexopoulos GS, Meyers BS, Flint AJ. Health-related quality of life in remitted psychotic depression?. J Affect Disord. 2019 09 01; 256:373-379.
    View in: PubMed
    Score: 0.030
  2. Davies SJ, Mulsant BH, Flint AJ, Meyers BS, Rothschild AJ, Whyte EM, Kirshner MM, Sorisio D, Pollock BG, Bies RR. SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study. Hum Psychopharmacol. 2016 05; 31(3):252-5.
    View in: PubMed
    Score: 0.024
  3. Rothschild AJ. The diagnosis and treatment of late-life depression. J Clin Psychiatry. 1996; 57 Suppl 5:5-11.
    View in: PubMed
    Score: 0.024
  4. Rothschild AJ. Delirium: an SSRI-benztropine adverse effect? J Clin Psychiatry. 1995 Nov; 56(11):537.
    View in: PubMed
    Score: 0.023
  5. Ulbricht CM, Dumenci L, Rothschild AJ, Lapane KL. Changes in Depression Subtypes Among Men in STAR*D: A Latent Transition Analysis. Am J Mens Health. 2018 Jan; 12(1):5-13.
    View in: PubMed
    Score: 0.023
  6. Deligiannidis KM, Rothschild AJ, Barton BA, Kroll-Desrosiers AR, Meyers BS, Flint AJ, Whyte EM, Mulsant BH. A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures. J Clin Psychiatry. 2013 Oct; 74(10):1003-9.
    View in: PubMed
    Score: 0.020
  7. Blumberger DM, Mulsant BH, Kanellopoulos D, Whyte EM, Rothschild AJ, Flint AJ, Meyers BS. The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression. J Clin Psychopharmacol. 2013 Jun; 33(3):391-7.
    View in: PubMed
    Score: 0.020
  8. Weissman J, Flint A, Meyers B, Ghosh S, Mulsant B, Rothschild A, Whyte E. Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression. Psychiatry Res. 2012 May 30; 197(3):221-6.
    View in: PubMed
    Score: 0.018
  9. Dunlop BW, Li T, Kornstein SG, Friedman ES, Rothschild AJ, Pedersen R, Ninan P, Keller M, Trivedi MH. Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder. J Psychiatr Res. 2011 Jan; 45(1):96-103.
    View in: PubMed
    Score: 0.016
  10. Flint AJ, Peasley-Miklus C, Papademetriou E, Meyers BS, Mulsant BH, Rothschild AJ, Whyte EM. Effect of age on the frequency of anxiety disorders in major depression with psychotic features. Am J Geriatr Psychiatry. 2010 May; 18(5):404-12.
    View in: PubMed
    Score: 0.016
  11. Schaffer A, Flint AJ, Smith E, Rothschild AJ, Mulsant BH, Szanto K, Peasley-Miklus C, Heo M, Papademetriou E, Meyers BS. Correlates of suicidality among patients with psychotic depression. Suicide Life Threat Behav. 2008 Aug; 38(4):403-14.
    View in: PubMed
    Score: 0.014
  12. Smith E, Rothschild AJ, Heo M, Peasley-Miklus C, Caswell M, Papademetriou E, Flint AJ, Mulsant BH, Meyers BS. Weight gain during olanzapine treatment for psychotic depression: effects of dose and age. Int Clin Psychopharmacol. 2008 May; 23(3):130-7.
    View in: PubMed
    Score: 0.014
  13. Rothschild AJ, Schatzberg AF, Rosenbaum AH, Stahl JB, Cole JO. The dexamethasone suppression test as a discriminator among subtypes of psychotic patients. Br J Psychiatry. 1982 Nov; 141:471-4.
    View in: PubMed
    Score: 0.010
  14. Hudson JI, Lipinski JF, Keck PE, Aizley HG, Lukas SE, Rothschild AJ, Waternaux CM, Kupfer DJ. Polysomnographic characteristics of young manic patients. Comparison with unipolar depressed patients and normal control subjects. Arch Gen Psychiatry. 1992 May; 49(5):378-83.
    View in: PubMed
    Score: 0.005
  15. Schatzberg AF, Rothschild AJ, Gerson B, Lerbinger JE, Schildkraut JJ. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity. Br J Psychiatry. 1985 Jun; 146:633-7.
    View in: PubMed
    Score: 0.003
  16. Rosenbaum AH, Schatzberg AF, MacLaughlin RA, Snyder K, Jiang NS, Ilstrup D, Rothschild AJ, Kliman B. The dexamethasone suppression test in normal control subjects: comparison of two assays and effect of age. Am J Psychiatry. 1984 Dec; 141(12):1550-5.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.